In translational studies, Gal-3 has shown strong associations with AKI severity, proteinuria burden, and progression of CKD, including in patients with diabetes, cardiovascular disease, and autoimmune nephropathies. This evidence concerns the gene LGALS3 and chronic kidney disease.